Education, Science, Technology, Innovation and Life
Open Access
Sign In

Research on treating leukemia with the "method of harmonizing qi and blood"

Download as PDF

DOI: 10.23977/medcm.2024.060113 | Downloads: 4 | Views: 141

Author(s)

Du Mengqiao 1, Du Xu 1, Yin Kejing 2, Li Min 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China
2 Yin Kejing Studio, The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China

Corresponding Author

Du Xu

ABSTRACT

Leukoaraiosis belongs to the category of "Fox and Confusion Disease" in Chinese medicine, which is a systemic vascular inflammatory disease caused by autoimmune system disorder. The causative factors of the disease include dampness, heat, insect, poison, stasis, etc. The main responsibility is dampness, heat and toxicity. Prof. Yin Kejing believes that the basic pathogenesis of the disease is the loss of harmony between qi and blood, and damage to collaterals and veins, and the evidence of this is the deficiency of the standard and the actuality of the symptoms, and the treatment should be to regulate qi and blood as the main method, and the identification of the meridian, the identification of the period of the combination of the right and the right to eliminate the evil.

KEYWORDS

Leukoaraiosis; Fuchsia; Harmonization of qi and blood; Famous doctor's experience; Yin Kejing

CITE THIS PAPER

Du Mengqiao, Du Xu, Yin Kejing, Li Min, Research on treating leukemia with the "method of harmonizing qi and blood". MEDS Chinese Medicine (2024) Vol. 6: 90-98. DOI: http://dx.doi.org/10.23977/medcm.2024.060113.

REFERENCES

[1] Zhu Hongfen, Zheng Danfeng. A case of leukemia combined with acute mononuclear cell leukemia[J]. Chinese Journal of Health Inspection, 2023, 33(04):463-466.
[2] MA Hai-Man, LIANG Xian-Hong, GE Xiao-Fei. Clinical observation on the treatment of leukemia by traditional Chinese medicine combined with thalidomide tablets[J]. China Traditional Chinese Medicine Modern Distance Education, 2020, 18(19):126-129.
[3] Nonaka D, Takase H, Machii M, et al. Colchicine therapy for deep vein thrombosis in a patient with vascular-type Behçet disease: a case report [J]. Medicine ( Baltimore), 2020, 99 (16). 
[4] Gu Bowen. Clinical observation on the treatment of heart-spleen heat accumulation type Behçet's disease by clearing heart and diarrhea, removing dampness and detoxification [D]. Heilongjiang University of Traditional Chinese Medicine, 2022. 
[5] WAN Yingying, MA Weiguo, ZHANG Chunyan et al. Discussion on the treatment of leukoencephalopathy with the addition and subtraction of subliminal yang pian mian dan[J]. Modern Chinese medicine, 2020, 40(02):33-34. 
[6] Zhang Zhiyan. Clinical study on the treatment of leukoaraiosis syndrome by self-designed Qingdai san[J]. Chinese medicine clinical research, 2014, 6(35):121-123.
[7] ZHANG ZhuoLi, PENG JinMin, HOU Xiaomeng, et al. Clinical meta-analysis of 1996 cases of leukoaraiosis [J]. Beijing medicine, 2007, 29(1): 10-12.
[8] Davatchi F, Chams-Davatchi C, Shams H, et al. Behcet's disease: epidemiology, clinical manifestations, and diagnosis[J].Expert Rev ClinImmunol. 2017, 13(1): 57-65.
[9] Zhang Meijuan, Wang Peixian. Recent advances in leukoaraiosis and its cardiovascular damage[J]. Chinese Cardiovascular Journal, 2023, 28(01):84-88.
[10] Zheng WJ. Emphasis on leukemia vasculopathy [J]. Chinese Journal of Rheumatology, 2016, 20 (12): 793-795.
[11] Nonaka D, Takase H, Machii M, et al. Colchicine therapy for deep vein thrombosis in a patient with vascular-type Behçet disease: a case report[J]. Medicine, 2020, 99(16).
[12] Wu Yiling, Jia Zhenhua, Chang Liping et al. Research on the prevention and treatment of vascular lesions guided by the theory of Ying and Wei in the theory of veins and collaterals[J]. Chinese Journal of Experimental Formulary, 2019, 25(01):1-10. 
[13] Wu Yiling. The doctrine of Chinese medicine and the three-dimensional network system[J]. Journal of Traditional Chinese Medicine, 2003(06):407-409. 
[14] Huang Wei, Yu Jiangwei, Yu Guojun et al. Clinical guidance of qi and blood doctrines in the Yellow Emperor's Classic of Internal Medicine[J]. Electronic Journal of Integrative Cardiovascular Disease of Chinese and Western Medicine, 2018, 6(13):17+19. 
[15] Zhang Weibo. Analysis of the concept of qi and blood meridians in the Yellow Emperor's Classic of Internal Medicine [J]. Chinese Acupuncture and Moxibustion, 2013, 33(08):708-716.
[16] Gong Aimin, Sang Xisheng, Wang Yiqin. Treatment of painful diarrhea by regulating qi and blood[J]. Chinese Journal of Traditional Chinese Medicine, 2007(10):2161-2163. 
[17] JIANG Jianping, SHEN Xiaoqing, FAN Haizhu. Progress of chemical composition and pharmacological activity of Dibotryon [J]. Chinese Journal of Traditional Chinese Medicine, 2011, 29(12).
[18] Du Mengfan, Xiang R, Fan Yu et al. Progress of pharmacological effects and anti-inflammatory mechanism of Serratia marcescens[J]. Journal of Yunnan College of Traditional Chinese Medicine, 2020, 43(06):92-98. 
[19] CHENG Shuangjie, LI Yan, YUAN Zhiqing et al. Progress in the study of chemical composition and pharmacological effects of Quemoy[J]. Chinese Journal of Traditional Chinese Medicine, 2021, 39(03):134-139.
[20] CHEN Ruixin, LIANG Songting, DAI Zhonghua et al. Progress of chemical composition and pharmacological activity of Polygonum aviculare[J]. Traditional Chinese Medicine, 2023, 45(06):1929-1936.
[21] FAN Lanlan, LU Lifei, WANG Xiaoxun et al. Progress of research on pharmacological effects and clinical application of Baibei[J]. Chinese Ethnic and Folk Medicine, 2017, 26(08):55-59.
[22] ZHANG Xuelin, CHEN Xinwang, WU Yiming. Progress in the study of chemical composition and pharmacological activity of volatile oil of Ailanthus spp. in the past 10 years [J]. Chinese Journal of Traditional Chinese Medicine, 2021, 39(05): 111-118. 

Downloads: 4191
Visits: 164792

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.